Pharmaceutical industry news, articles, jobs, reports, advice and services, what is the pharmaceutical industry.#What #is #the #pharmaceutical #industry

Posted On Jan 16 2018 by

First Herceptin biosimilar cleared in Europe Ontruzant is approved for all the same indications as Roche s blockbuster EMA forges closer ties with HTA umbrella group Agrees joint work plan with the European Network for Health Technology Assessment Novartis’ orphan drug Tasigna wins EU expanded indication The CML medication can now treat paediatric patients Amsterdam picked to host the European Medicines Agency But regulator faces a challenging relocation project to depart from London Concordia accused of overcharging NHS for thyroid drug The pharma firm said to have abused its position within the UK market Sales news Research news The state …


Persuading the Prescribers: Pharmaceutical Industry Marketing and its Influence on Physicians and Patients – Pew Charitable Trusts, the pharmaceutical industry.#The #pharmaceutical #industry

Posted On Jan 15 2018 by

Persuading the Prescribers: Pharmaceutical Industry Marketing and its Influence on Physicians and Patients In 2012, the pharmaceutical industry spent more than $27 billion on drug promotion 1 more than $24 billion on marketing to physicians and over $3 billion on advertising to consumers (mainly through television commercials). 2 This approach is designed to promote drug companies’ products by influencing doctors’ prescribing practices. 3 2013 The Pew Charitable Trusts Source: Cegedim Strategic Data, 2012 U.S. Pharmaceutical Company Promotion Spending (2013). Detailing: This marketing approach refers to face-to-face promotional activities directed toward physicians and pharmacy directors. Pharmaceutical representatives typically visit doctors to …


Pharmaceutical industry news, articles, jobs, reports, advice and services, the pharmaceutical industry.#The #pharmaceutical #industry

Posted On Jan 15 2018 by

First Herceptin biosimilar cleared in Europe Ontruzant is approved for all the same indications as Roche s blockbuster EMA forges closer ties with HTA umbrella group Agrees joint work plan with the European Network for Health Technology Assessment Novartis’ orphan drug Tasigna wins EU expanded indication The CML medication can now treat paediatric patients Amsterdam picked to host the European Medicines Agency But regulator faces a challenging relocation project to depart from London Concordia accused of overcharging NHS for thyroid drug The pharma firm said to have abused its position within the UK market Sales news Research news The state …


How will the pharmaceutical industry evolve on drug pricing, PBS NewsHour, jobs in the pharmaceutical industry.#Jobs #in #the #pharmaceutical #industry

Posted On Jan 13 2018 by

How will the pharmaceutical industry evolve on drug pricing? High drug prices are a constant consumer complaint about health care. Judy Woodruff sits down with Stephen Ubl, president and CEO of the Pharmaceutical Research and Manufacturers of America, at the Spotlight Health Conference at the Aspen Institute to discuss the Senate Republican health care bill, the prospects for lowering drug prices and the connection between the opioid crisis and the industry. Read the Full Transcript As the battle over health care rages in Congress, one constant complaint from consumers is over drug prices. Judy Woodruff is in Colorado with our …


The Fortune 500 s fastest-growing pharmaceutical companies #pharmaceutical #machinery

Posted On Jan 8 2018 by

#pharmaceutical industry growth # These are the Fortune 500’s fastest-growing pharma companies The pharmaceutical industry has been rocked in recent years by a confluence of patent expirations of blockbuster drugs, increasing competition from generics and new governmental and industry efforts to control costs the world over. That s made growth prospects for many pharma companies a risky and uncertain proposition. Some have pursued growth via innovative (and expensive) new drugs, like Gilead Science s hepatitis C treatment, Sovaldi, which can cost $84,000 for a full course. Some (see: Actavis) have pursued an aggressive acquisition strategy, buying their way to growth …


Are we witnessing the demise of big pharma? Channel 4 News #new #pharmaceutical #companies

Posted On Jan 8 2018 by

#big pharma jobs # Like most websites Channel 4 uses cookies. In order to deliver a personalised, responsive service and to improve the site, we remember and store information about how you use it. This is done using simple text files called cookies which sit on your computer. These cookies are completely safe and secure and will never contain any sensitive information. They are used only by Channel 4 or the trusted partners we work with. How to manage cookies In order to deliver an optimised service, Channel 4 uses cookies. These are simple text files which sit on your …


The year s top pharma marketing controversies – Medical Marketing and Media #pharmaceutical #companies #in #nyc

Posted On Jan 8 2018 by

#marketing pharmaceuticals # December 23, 2015 The year’s top pharma marketing controversies Photo credit: Bill Brooks/Creative Commons 1. Drug pricing goes public: In the past year, what was once an issue debated among few stakeholders in the medical community became a talking point in presidential campaigns. (Bill Clinton’s words of advice to pharma: “Explain, explain, explain; disclose, disclose, disclose.”) The issue of how and why drugs are priced the way they are hit a tipping point, as insurers, pharmacy benefit managers, physicians and even presumptive presidential candidates questioned pharmaceutical pricing practices and called for changes to the current system. 2. …


Sun Pharma inks pact to buy DUSA for $230 million – The Hindu #international #pharma #jobs

Posted On Jan 7 2018 by

#dusa pharma # Sun Pharma inks pact to buy DUSA for $230 million Sun Pharmaceutical Industries, on Thursday, said it had inked a pact to acquire U.S.-based DUSA Pharmaceuticals for around $230 million (about Rs.1,250 crore). Sun Pharma and DUSA Pharmaceuticals have entered into a definitive agreement under which Sun Pharma will acquire DUSA, a dermatology company focused on developing and marketing its Levulan photo-dynamic therapy platform, Sun Pharma said in a statement. Under the terms of the agreement, a 100 per cent subsidiary of Sun Pharma will commence a tender offer for all of the outstanding common stock of …


The Future of the Pharmaceutical Industry is in Emerging Markets – Pharmaceutical Compliance Monitor #pharma #market #access

Posted On Jan 7 2018 by

#future of pharmaceutical industry # The Future of the Pharmaceutical Industry is in Emerging Markets When growth at home slows, smart companies expand abroad. Stagnation suffocates a company’s growth, so when profits start to level out after years of growth, smart companies immediately begin to scour the globe for new sources of revenue to move their organizations back into a more profitable position. For the pharmaceutical industry, expanding into emerging markets is inevitable and will prove to be a critical step in the industry’s evolution, despite initial growing pains. Let’s take a step back and look at the commonly accepted …


The 5-Minute Guide to Horizon Pharma PLC Stock – The Motley Fool #valeant #pharma

Posted On Jan 7 2018 by

#horizon pharma # The 5-Minute Guide to Horizon Pharma PLC Stock Value investors don’t need to know a mitochondria from a hole in the ground to sense something’s amiss with Horizon Pharmaceuticals (NASDAQ:HZNP ) stock. Over the past several years the company’s sales have exploded, yet the stock fallen roughly 50% from its peak last summer. With a forward price-to-earnings ratio under 10, this looks like a bargain hunter’s dream come true. Before you go diving in, take five minutes to familiarize yourself with this company. You’ll be glad you did. Pharma-funds Even if you don’t follow pharmaceutical industry news, …